Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprotinin in Bladder Cancer Cystectomy
NCT00306150Phase 3Terminated
- Sponsor
- Bayer
- Start
- Dec 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial comparing Aprotinin with Placebo (2 arms). Primary endpoint: Percent of patients requiring a blood transfusion. Started Dec 2005; status: terminated.
02
Drugs
aprotinin
Beyond the preview
Go deeper on NCT00306150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306150.